Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28819738
Publication Date : 2017/08/18

High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience.


High-dose capsaicin patch is effective in treatment of neuropathic pain in HIV-associated neuropathy and diabetic neuropathy. There are no studies assessing effectiveness of high-dose capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy. We sought to determine the effectiveness of treatment of pain associated with chemotherapy-induced peripheral neuropathy with high-dose capsaicin patch. Our study group consisted of 18 patients with clinically confirmed oxaliplatin-induced neuropathy. Baseline characteristic including underling disease, received cumulative dose of neurotoxic agent, neuropathic symptoms, prior treatment and initial pain level were recorded. Pain was evaluated with Numeric Rating Scale prior to treatment with high-dose capsaicin and after 1.8 day and after 8 and 12 weeks after introducing treatment. Patients were divided into two groups accordingly to the amount of neurotoxic agent that caused neuropathy (high sensitivity and low sensitivity group). Most frequent symptoms of chemotherapy-induced neuropathy were: pain (88.89%), paresthesis (100%), sock and gloves sensation (100%) and hypoesthesis (100%). Initial pain level was 7.45 ± 1.14. Mean cumulative dose of oxaliplatin after which patients developed symptoms was 648.07 mg/m(2). Mean pain level after 12 weeks of treatment was 0.20 ± 0.41. When examined according to high and low sensitivity to neurotoxic agent patients with low sensitivity had higher pain reduction, especially after 8 days after introducing treatment (69.55 ± 12.09 vs. 49.40 ± 20.34%; p = 0.02) and after 12 weeks (96.96 ± 5.56 vs. 83.93 ± 18.59%; p = 0.04). High-dose capsaicin patch is an effective treatment for pain associated with chemotherapy-induced neuropathy in patients treated with oxaliplatin. Patients with lower sensitivity to neurotoxic agents have better response to treatment and pain reduction.

Authors : Filipczak-Bryniarska Iwona , Krzyzewski Roger M , Kucharz Jakub , Michalowska-Kaczmarczyk Anna , Kleja Justyna , Woron Jarosław , Strzepek Katarzyna , Kazior Lucyna , Wordliczek Jerzy , Grodzicki Tomasz , Krzemieniecki Krzysztof ,

Related products :

Catalog number Product name Quantity
orb60245 Dacarbazine Dacarbazine(DTIC-Dome) is an antineoplastic chemotherapy drug used in the treatment of various cancers. For research use only. 5 mg
orb60366 Isotretinoin It was developed to be used as a chemotherapy medication for the treatment of brain cancer, pancreatic cancer and more. For research use only. 1 g
orb60315 Streptozotocin Streptozotocin(Streptozocin, Zanosar, STZ) is a naturally occurring chemical used in cancer chemotherapy and Type 1 diabetes treatment. For research use only. 500 mg
K2-BFU2-2RH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Rat 2 Plate Kits
K2-BFU2-4RH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Rat 4 Plate Kits
K2-BFU2-2CH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Dog 2 Plate Kits
K2-BFU2-4CH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Dog 4 Plate Kits
K2-BFU2-4PrH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2,NHP 4 Plate Kits
K2-BFU2-2PrH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2,NHP 2 Plate Kits
K2-BFU2-4HH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Human 4 Plate Kits
K2-BFU2-4MH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Mouse 4 Plate Kits
K2-BFU2-2HH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Human 2 Plate Kits
K2-BFU2-2MH HALO-Tox HT, GFS: EPO (high dose), Population: BFU-E 2, Mouse 2 Plate Kits
K3-BFU2-2RH HALO-384 Tox Assay Kits, GFS: EPO (high dose), Population: BFU-E 2, Rat 2 Plate Kits
K3-BFU2-2CH HALO-384 Tox Assay Kits, GFS: EPO (high dose), Population: BFU-E 2, Dog 2 Plate Kits
K3-BFU2-4CH HALO-384 Tox Assay Kits, GFS: EPO (high dose), Population: BFU-E 2, Dog 4 Plate Kits
K3-BFU2-4RH HALO-384 Tox Assay Kits, GFS: EPO (high dose), Population: BFU-E 2, Rat 4 Plate Kits
K3-BFU2-4PrH HALO-384 Tox Assay Kits, GFS: EPO (high dose), Population: BFU-E 2, NHP 4 Plate Kits
K3-BFU2-2PrH HALO-384 Tox Assay Kits, GFS: EPO (high dose), Population: BFU-E 2, NHP 2 Plate Kits
K3-BFU2-2HH HALO-384 Tox Assay Kits, GFS: EPO (high dose), Population: BFU-E 2, Human 2 Plate Kits
K3-BFU2-2MH HALO-384 Tox Assay Kits, GFS: EPO (high dose), Population: BFU-E 2, Mouse 2 Plate Kits
K3-BFU2-4MH HALO-384 Tox Assay Kits, GFS: EPO (high dose), Population: BFU-E 2, Mouse 4 Plate Kits
K3-BFU2-4HH HALO-384 Tox Assay Kits, GFS: EPO (high dose), Population: BFU-E 2, Human 4 Plate Kits
303-08741 tic and noncataractous), renal proximal tubules in patients with diabetic nephropathy and chronic renal failure, diabetic retina, peripheral nerves of diabetic neuropathy, atherosclerotic lesions of a 20UG
orb60755 Capsaicin Capsaicin(Qutenza) is an active component of chili peppers, which are plants belonging to the genus Capsicum. For research use only. 100 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur